로딩 중…
지수 로딩 중…
Fulcrum Therapeutics, Inc.
FULC· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.70+5.71%
2026-06-18
Price Chart
Fulcrum Therapeutics, Inc.-41.82%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $247M |
| Revenue | $0.00 |
| Net Income | $-76M |
| Total Assets | $347M |
| Net Assets | $333M |
| Value | |
| P/B | 0.74x |
| FCF Yield | -25.91% |
| Profitability | |
| ROE | -22.84% |
| ROA | -21.95% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 4.04% |
| Total Debt | $6M |
| FCF | $-64M |
| Cash | $50M |
| Current Ratio | 34.33x |
| Performance | |
| 1Y Return | -41.82% |
| 1M Return | -37.39% |
| From 52W High | -76.49% |
| 1Y MDD | -78.49% |
| Trading | |
| Volume | 6,054,370 shares |
| Trading Value | $22M |
| Per Share | |
| EPS | $-1.18 |
| BPS | $5.51 |